Treatment of Advanced Hepatocellular Carcinoma after Failure of Sorafenib Treatment: Subsequent or Additional Treatment Interventions Contribute to Prolonged Survival Postprogression.

Masaaki Kondo Kazushi NumataKoji HaraAkito NozakiHiroyuki FukudaMakoto ChumaShin MaedaKatsuaki Tanaka

Published in: Gastroenterology research and practice (2017)

SPP is closely associated with OS and might be notable in patients who have failed to respond to initial sorafenib treatment. Furthermore, interventions consisting of other treatment options upon the appearance of progression might prolong OS.

Keyphrases

physical activity
end stage renal disease
chronic kidney disease
ejection fraction
patient reported outcomes
prognostic factors
peritoneal dialysis